BDBM50133617 1-Benzyl-5-iodo-1H-indole-2,3-dione::1-benzyl-5-iodoindoline-2,3-dione::CHEMBL118596
SMILES: Ic1ccc2N(Cc3ccccc3)C(=O)C(=O)c2c1
InChI Key: InChIKey=GXSCFBFBNQZZJL-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Papain-like protease (PLpro) (Human SARS coronavirus (SARS-CoV)) | BDBM50133617 (1-Benzyl-5-iodo-1H-indole-2,3-dione | 1-benzyl-5-i...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Peking University Curated by ChEMBL | Assay Description Inhibition of SARS CoV 3C-like protease | J Med Chem 49: 3440-3 (2006) Article DOI: 10.1021/jm0602357 BindingDB Entry DOI: 10.7270/Q2TD9WZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM50133617 (1-Benzyl-5-iodo-1H-indole-2,3-dione | 1-benzyl-5-i...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cruzipain (Trypanosoma cruzi) | BDBM50133617 (1-Benzyl-5-iodo-1H-indole-2,3-dione | 1-benzyl-5-i...) | PDB MMDB UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 9.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Cape Town Curated by ChEMBL | Assay Description Inhibitory activity against the Trypanosoma cruzi cysteine protease cruzain | Bioorg Med Chem Lett 13: 3527-30 (2003) BindingDB Entry DOI: 10.7270/Q2SQ8ZSX | |||||||||||
More data for this Ligand-Target Pair |